|
|
Triggering NSF
- Article from:
-
Dermatology Times
- Article date:
-
June 1, 2008
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Jun 2008. Provided by ProQuest LLC. (Hide copyright information)
|
Researchers look at role of gadolinium
New Haven, Conn.-Accumulating research findings suggest exposure to gadolinium through the use of a gadolinium-containing contrast agent (GCCA) may be a trigger in the development of nephrogenic systemic fibrosis (NSF), and there is also some evidence indicating the type of GCCA may influence the risk.
Definitive cause-and-effect relationships have yet to be established, according to Shawn Cowper, M.D.
NSF was first described in the literature in 2001, and was originally referred to as nephrogenic fibrosing dermopathy, because it was not initially appreciated to be a systemic disorder. While the pathogenesis of NSF is still being investigated, in ...